Histamine H3 receptor agents, preparation and therapeutic uses

Details for Australian Patent Application No. 2006232871 (hide)

Owner Eli Lilly and Company

Inventors Takakuwa, Takako; Hipskind, Philip Arthur; Gadski, Robert Alan; Pickard, Richard Todd; Hornback, William Joseph; Beavers, Lisa Selsam; Jesudason, Cynthia Darshini

Agent Spruson & Ferguson

Pub. Number AU-B-2006232871

PCT Pub. Number WO2006/107661

Priority 60/667,582 01.04.05 US

Filing date 28 March 2006

Wipo publication date 12 October 2006

Acceptance publication date 17 November 2011

International Classifications

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/107661 Priority application(s): WO2006/107661

17 November 2011 Application Accepted

  Published as AU-B-2006232871

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006232873-Sprinkler assembly

2006232867-Video poker system and method with player card selection